Lau YM - Search Results

1

Can ChatGPT Provide Quality Information on Integrative Oncology? A Brief Report.

Lam CS, Hua R, Koon HK, Zhou KR, Lam TTN, Lee CP, Lin WL, Wong CL, Lau YM, Loong HH, Chung VC, Cheung YT. Lam CS, et al. Among authors: lau ym. J Integr Complement Med. 2024 Feb;30(2):196-205. doi: 10.1089/jicm.2023.0290. Epub 2023 Oct 4. J Integr Complement Med. 2024. PMID: 37792344

2

Therapeutic Strategies in EGFR Mutant Non-Small Cell Lung Cancer.

Loong HH, Kwan SS, Mok TS, Lau YM. Loong HH, et al. Among authors: lau ym. Curr Treat Options Oncol. 2018 Sep 29;19(11):58. doi: 10.1007/s11864-018-0570-9. Curr Treat Options Oncol. 2018. PMID: 30267319 Review.

3

Have We Revealed the Achilles' Heel of Brigatinib? Implications on Clinical Practice.

Loong HH, Li MSC, Tang GCH, Lau YM. Loong HH, et al. Among authors: lau ym. J Thorac Oncol. 2020 Jul;15(7):1100-1102. doi: 10.1016/j.jtho.2020.03.026. J Thorac Oncol. 2020. PMID: 32593441 Free article. No abstract available.

4

Prevalence and prognostic impact of comorbidities and peripheral blood indices in sarcomas.

Loong HH, Wong CKH, Wei Y, Kwan SSC, Zhang Y, Tse T, Lau YM, Leung LKS, Tang GCH. Loong HH, et al. Among authors: lau ym. ESMO Open. 2020 Nov;5(6):e001035. doi: 10.1136/esmoopen-2020-001035. ESMO Open. 2020. PMID: 33214228 Free PMC article.

5

Brief Report: Risk of Recurrent Interstitial Lung Disease From Osimertinib Versus Erlotinib Rechallenge After Symptomatic Osimertinib-Induced Interstitial Lung Disease.

Li MSC, Lee KWC, Mok KKS, Loong HHF, Lam KC, Mok FST, Chan LL, Lau YM, Chan KP, Ng JTY, Wong WKY, Lam BHW, Chen ACC, Lee MMP, Chen OH, Mok TSK. Li MSC, et al. Among authors: lau ym. JTO Clin Res Rep. 2024 Feb 10;5(4):100648. doi: 10.1016/j.jtocrr.2024.100648. eCollection 2024 Apr. JTO Clin Res Rep. 2024. PMID: 38590729 Free PMC article.

6

Testing for EGFR Variants in Pleural and Pericardial Effusion Cell-Free DNA in Patients With Non-Small Cell Lung Cancer.

Lee KWC, Li MSC, Gai W, Lau YM, Chan AKC, Chan OSH, Lee CK, Yeung RMW, Fung SYH, Cheung WF, Chan VW, Leung L, Kam KNP, Mok TSK. Lee KWC, et al. Among authors: lau ym. JAMA Oncol. 2023 Feb 1;9(2):261-265. doi: 10.1001/jamaoncol.2022.6109. JAMA Oncol. 2023. PMID: 36580285 Free PMC article.

7

Risks and impacts of thromboembolism in patients with pancreatic cancer.

Chan LL, Lam KY, Lam DCM, Lau YM, Li L, Ng KKC, Tang RSY, Chan SL. Chan LL, et al. Among authors: lau ym. Hong Kong Med J. 2023 Oct;29(5):396-403. doi: 10.12809/hkmj219788. Epub 2023 Oct 4. Hong Kong Med J. 2023. PMID: 37789507 Free article.

8

The More, The Better?

Lau YM, Mok TSK. Lau YM, et al. J Clin Oncol. 2020 Nov 1;38(31):3581-3583. doi: 10.1200/JCO.20.02108. Epub 2020 Sep 8. J Clin Oncol. 2020. PMID: 32897826 No abstract available.

9

Best practices in epidermal growth factor receptor T790M testing for advanced non-small-cell lung cancer in Hong Kong.

Nyaw JSF, Cheung KM, Hioe F, Kam MTY, Lau JKS, Lau YM, Leung DKC, Lim FMY. Nyaw JSF, et al. Among authors: lau ym. Hong Kong Med J. 2023 Jun;29(3):240-246. doi: 10.12809/hkmj219632. Hong Kong Med J. 2023. PMID: 37349139 Free article.

10

Elfin is expressed during early heart development.

Kotaka M, Lau YM, Cheung KK, Lee SM, Li HY, Chan WY, Fung KP, Lee CY, Waye MM, Tsui SK. Kotaka M, et al. Among authors: lau ym. J Cell Biochem. 2001 Aug 21-Sep 5;83(3):463-72. doi: 10.1002/jcb.1244. J Cell Biochem. 2001. PMID: 11596114

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

56 results

Search Page